An Act prohibiting the sale of dextromethorphan to minors
Massachusetts bill restricts over-the-counter dextromethorphan sales to minors to prevent substance abuse while maintaining access through adult purchase and parental authorization.
Massachusetts bill restricts over-the-counter dextromethorphan sales to minors to prevent substance abuse while maintaining access through adult purchase and parental authorization.
H 2481 would prohibit the sale of dextromethorphan (DXM), a common cough suppressant found in over-the-counter cold medicines, to individuals under 18 years old in Massachusetts. The bill restricts retail access to this medication for minors, similar to age-restriction models used for other products.
DXM abuse among adolescents has been documented as a public health concern, with misuse potentially causing neurological effects, overdose, and other serious health complications. This legislation attempts to reduce youth access to a substance that can be easily obtained and misused when taken in large quantities beyond therapeutic doses. The measure balances public health protection with maintaining access for legitimate medical use by adults and supervised use by minors through parental or medical channels.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.